Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Northwest Biotherapeutics (NWBO) Change in Intangibles (2009 - 2010)

Updated

Analysis

Northwest Biotherapeutics (NWBO) Change in Intangibles (2009 - 2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.06 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 995.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -7.20 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Northwest Biotherapeutics 283.78 Mn 273.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2010 -1.82 Mn
Mar 31, 2010 1.82 Mn
Mar 31, 2009 1.82 Mn
API Access

Northwest Biotherapeutics Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=NWBO&period=max&api_key=YOUR_API_KEY